Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,153 | 327 | 67.6% |
| Honoraria | $2,000 | 1 | 18.9% |
| Travel and Lodging | $1,352 | 1 | 12.8% |
| Education | $79.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Integra GPO, LLC | $3,695 | 3 | $0 (2019) |
| Astellas Pharma US Inc | $1,455 | 90 | $0 (2024) |
| NeoTract Inc. | $517.18 | 9 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $418.07 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $403.67 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $369.81 | 14 | $0 (2020) |
| ABBVIE INC. | $319.64 | 24 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $297.27 | 11 | $0 (2024) |
| Medtronic USA, Inc. | $272.46 | 9 | $0 (2020) |
| C. R. Bard, Inc. & Subsidiaries | $237.30 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689.03 | 35 | ABC Home Medical Supply, Inc. ($63.10) |
| 2023 | $527.53 | 30 | PFIZER INC. ($59.32) |
| 2022 | $698.50 | 30 | C. R. Bard, Inc. & Subsidiaries ($145.65) |
| 2021 | $722.16 | 27 | TOLMAR Pharmaceuticals, Inc. ($168.32) |
| 2020 | $779.62 | 29 | Astellas Pharma US Inc ($293.53) |
| 2019 | $4,946 | 57 | Integra GPO, LLC ($3,695) |
| 2018 | $920.29 | 53 | Astellas Pharma US Inc ($361.50) |
| 2017 | $1,302 | 69 | Astellas Pharma US Inc ($257.51) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Urology | ||||||
| 10/17/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: BLADDER | ||||||
| 10/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: Urology | ||||||
| 08/30/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diagnostic Imaging | ||||||
| 08/15/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: AMS 700_URO | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Oncology | ||||||
| 07/31/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $22.65 | General |
| 07/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diagnostic Imaging | ||||||
| 06/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/13/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 05/15/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/10/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: rezum_URO | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 03/20/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,563 | 6,011 | $698,624 | $160,736 |
| 2022 | 28 | 2,605 | 6,486 | $672,701 | $169,934 |
| 2021 | 32 | 2,684 | 5,198 | $732,964 | $162,946 |
| 2020 | 26 | 2,628 | 5,629 | $592,297 | $147,696 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 503 | $101,716 | $41,810 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 302 | $35,302 | $16,147 | 45.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 104 | $74,870 | $13,980 | 18.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 105 | 254 | $51,176 | $11,934 | 23.3% |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | Office | 2023 | 16 | 192 | $17,907 | $6,603 | 36.9% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $33,641 | $6,127 | 18.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 11 | 13 | $50,127 | $5,374 | 10.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $17,241 | $5,194 | 30.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 19 | 2,177 | $11,286 | $4,791 | 42.4% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 100 | $19,254 | $4,651 | 24.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 192 | 240 | $25,616 | $4,325 | 16.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 75 | 96 | $9,706 | $3,683 | 37.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 20 | 58 | $17,887 | $3,610 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 56 | $7,570 | $3,410 | 45.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 18 | 23 | $16,564 | $3,234 | 19.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 80 | $7,440 | $2,821 | 37.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 13 | 14 | $25,841 | $2,657 | 10.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 510 | 787 | $18,748 | $2,442 | 13.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 62 | $9,684 | $2,215 | 22.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 35 | 40 | $29,473 | $2,212 | 7.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 253 | $3,930 | $2,125 | 54.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 24 | 29 | $35,191 | $2,080 | 5.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $13,691 | $1,965 | 14.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 18 | $18,548 | $1,622 | 8.7% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 60 | 100 | $8,382 | $1,399 | 16.7% |
About Dr. Michael Barkoukis, MD
Dr. Michael Barkoukis, MD is a Urology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740258128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Barkoukis, MD has received a total of $10,585 in payments from pharmaceutical and medical device companies, with $689.03 received in 2024. These payments were reported across 330 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,153).
As a Medicare-enrolled provider, Barkoukis has provided services to 10,480 Medicare beneficiaries, totaling 23,324 services with total Medicare billing of $641,311. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Cleveland, OH
- Active Since 03/10/2006
- Last Updated 01/14/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1740258128
Products in Payments
- XTANDI (Drug) $782.54
- MYRBETRIQ (Drug) $452.37
- UroLift (Device) $441.15
- ERLEADA (Drug) $401.37
- XIAFLEX (Biological) $305.92
- Xtandi (Drug) $301.80
- PROVENGE (Drug) $297.27
- Xofigo (Drug) $292.84
- INTERSTIM (Device) $292.12
- ELIGARD (Drug) $249.55
- ORGOVYX (Drug) $170.25
- Androgel (Drug) $163.28
- BOTOX (Biological) $159.95
- Noctiva (Drug) $128.14
- Nubeqa (Drug) $125.23
- XGEVA (Biological) $121.19
- JELMYTO (Drug) $116.11
- Myrbetriq (Drug) $101.85
- Prolia (Biological) $89.19
- FIRMAGON (Drug) $79.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cleveland
Howard Goldman, Md, MD
Urology — Payments: $688,743
Jihad Kaouk, Md, MD
Urology — Payments: $258,551
Sandip Vasavada, Md, MD
Urology — Payments: $247,878
Petar Bajic, M.d, M.D
Urology — Payments: $238,227
Dr. Sriharan Sivalingam, Md, MD
Urology — Payments: $210,140
Ruben Olivares, Md, MD
Urology — Payments: $174,034